@article{UBHD-68879631, author={Banz, Kurt and Bischoff, Helge and Brunner, Matthias and Chouaid, Christos and Castro Carpeño, Javier de and Marinis, Filippo de and Grossi, Francesco and Vergnenègre, Alain and Walzer, Stefan}, title={Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain}, year={2011}, pages={529-534}, language={eng}, issn={1872-8332}, volume={74}, number={3 vom: Dez.}, note={Gesehen am 17.02.2022}, journal={Lung cancer}, doi={10.1016/j.lungcan.2011.04.010}, } @article{UBHD-68254435, author={Bernhardt, Denise and Adeberg, Sebastian and Bozorgmehr, Farastuk and Opfermann, Nils and H{\"o}rner-Rieber, Juliane and Kappes, Jutta and Thomas, Michael and Bischoff, Helge and Herth, Felix and Heußel, Claus Peter and Debus, J{\"u}rgen and Steins, Martin and Rieken, Stefan}, title={Nine-year experience}, subtitle={prophylactic cranial irradiation in extensive disease small-cell lung cancer}, year={2017}, pages={e267-e271}, language={eng}, issn={1938-0690}, volume={18}, number={4}, note={Gesehen am 24.05.2018 ; Epub: Dec 2, 2016}, journal={Clinical lung cancer}, doi={10.1016/j.cllc.2016.11.012}, } @book{UBHD-2536853, author={Bischoff, Helge}, title={Chemotherapie eines Nitrosamin-induzierten autochthonen Colontumors bei SD-Ratten mmit -Diketonato-Verbindungen von Titan, Zirkonium und Hafnium, im Vergleich mit cis-Platin, Cyclophosphamid, 5-Fluorouracil und 5'Deoxy-5-Fluorouridin}, year={1986}, pages={144 Bl.}, language={ger}, school={Heidelberg, Univ., Diss., 1986 (Nicht f.d. Austausch)}, library={UB [Signatur: 87 U 53] ; UB [Signatur: 87 U 53]}, } @article{UBHD-68336450, author={Bischoff, Helge}, title={Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom}, subtitle={Ergebnisse einer Phase-III-Studie}, year={2016}, pages={598-599}, language={ger}, issn={1433-0415}, volume={22}, number={8}, note={Gesehen am 05.12.2018}, journal={Der Onkologe}, doi={10.1007/s00761-016-0066-9}, } @book{UBHD-68497601, author={Bischoff, Helge and Sch{\"o}nfeld, Nicolas}, title={Kodierleitfaden f{\"u}r die Pneumologie 2016}, subtitle={medizinische Dokumentation von Diagnosen und Leistungen}, edition={13. Aufl.}, publisher={medhochzwei}, address={Heidelberg}, year={2016}, pages={193 S.}, language={ger}, isbn={978-3-86216-259-8 and 3-86216-259-1}, series={Praxiswissen Abrechnung}, } @book{UBHD-68497543, author={Bischoff, Helge and Sch{\"o}nfeld, Nicolas}, title={Kodierleitfaden f{\"u}r die Pneumologie 2017}, subtitle={medizinische Dokumentation von Diagnosen und Leistungen}, edition={14. Auflage}, publisher={medhochzwei Verlag}, address={Heidelberg, Neckar}, year={2017}, pages={203 Seiten}, language={ger}, isbn={978-3-86216-317-5 and 3-86216-317-2}, series={Praxiswissen Abrechnung}, } @book{UBHD-68497603, author={Bischoff, Helge and Sch{\"o}nfeld, Nicolas}, title={Kodierleitfaden f{\"u}r die Pneumologie 2018}, subtitle={medizinische Dokumentation von Diagnosen und Leistungen}, edition={15. Auflage}, publisher={medhochzwei}, address={Heidelberg}, year={2018}, pages={203 Seiten}, language={ger}, isbn={978-3-86216-380-9 and 3-86216-380-6}, series={Praxiswissen Abrechnung}, } @book{UBHD-68497568, author={Bischoff, Helge and Sch{\"o}nfeld, Nicolas}, organization={medhochzwei Verlag GmbH}, title={Kodierleitfaden f{\"u}r die Pneumologie 2019}, subtitle={medizinische Dokumentation von Diagnosen und Leistungen}, edition={16. Auflage}, publisher={medhochzwei}, address={Heidelberg}, year={2019}, pages={209 Seiten}, language={ger}, isbn={3-86216-513-2 and 978-3-86216-513-1}, series={Praxiswissen Abrechnung}, } @book{UBHD-68497661, author={Bischoff, Helge and Sch{\"o}nfeld, Nicolas}, organization={medhochzwei Verlag GmbH}, title={Kodierleitfaden f{\"u}r die Pneumologie 2020}, subtitle={medizinische Dokumentation von Diagnosen und Leistungen}, edition={17. Auflage}, publisher={medhochzwei}, address={Heidelberg}, year={2020}, pages={221 Seiten}, language={ger}, isbn={978-3-86216-591-9 and 3-86216-591-4}, series={Praxiswissen Abrechnung}, } @article{UBHD-69038582, author={Bischoff, Helge and van den Borne, Ben and Pimentel, Francisco L. and Arellano, Jorge and Langer, Frank and Leschinger, Monika I. and Thatcher, Nicholas}, title={Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study)}, year={2010}, pages={1461-1470}, language={eng}, issn={1473-4877}, volume={26}, number={6}, note={Gesehen am 07.02.2023}, journal={Current medical research and opinion}, doi={10.1185/03007991003799180}, } @article{UBHD-68899224, author={Bischoff, Helge and Heigener, David F. and Walzer, Stefan and Nuijten, Mark}, title={Response to Letter to the editor}, year={2011}, pages={245}, language={eng}, issn={1872-8332}, volume={71}, number={2 vom: Feb.}, note={Gesehen am 24.03.2022 ; First published online: 30 December 2010}, journal={Lung cancer}, doi={10.1016/j.lungcan.2010.11.016}, } @article{UBHD-68955324, author={Blasi, Miriam and Eichhorn, Martin E. and Christopoulos, Petros and Winter, Hauke and Heußel, Claus Peter and Herth, Felix and El-Shafie, Rami and Kriegsmann, Katharina and Kriegsmann, Mark and Stenzinger, Albrecht and Bischoff, Helge and Thomas, Michael and Kuon, Jonas}, title={Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older}, subtitle={a propensity score-matched analysis}, year={2022}, pages={1-8}, language={eng}, issn={1471-2466}, volume={22}, number={Artikel-ID 255}, note={Gesehen am 18.08.2022}, journal={BMC pulmonary medicine}, doi={10.1186/s12890-022-02043-6}, url={https://doi.org/10.1186/s12890-022-02043-6}, library={UB}, } @article{UBHD-68401896, author={Christopoulos, Petros and Dietz, Steffen and Kirchner, Martina and Volckmar, Anna-Lena and Endris, Volker and Neumann, Olaf and Heußel, Claus Peter and Herth, Felix and Eichhorn, Martin E. and Meister, Michael and Budczies, Jan and Allg{\"a}uer, Michael and Leichsenring, Jonas and Bischoff, Helge and Schirmacher, Peter and Thomas, Michael and S{\"u}ltmann, Holger and Stenzinger, Albrecht}, title={Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival}, year={2019}, pages={9 S.}, language={eng}, issn={2072-6694}, volume={11(2019}, note={Gesehen am 26.06.2019 ; Im Titel ist das Zeichen "+" hochgestellt}, journal={Cancers}, doi={10.3390/cancers11010124}, url={https://doi.org/10.3390/cancers11010124}, library={UB}, } @article{UBHD-68389677, author={Christopoulos, Petros and Endris, Volker and Bozorgmehr, Farastuk and El Sayed, Mei and Kirchner, Martina and Ristau, Jonas and Buchhalter, Ivo and Penzel, Roland and Herth, Felix and Heußel, Claus Peter and Eichhorn, Martin E. and Muley, Thomas and Meister, Michael and Rieken, Stefan and Warth, Arne and Bischoff, Helge and Schirmacher, Peter and Stenzinger, Albrecht and Thomas, Michael}, title={EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer}, year={2018}, pages={2589-2598}, language={eng}, issn={1097-0215}, volume={142}, number={12}, note={First published: 24 January 2018 ; Gesehen am 14.05.2019}, journal={International journal of cancer}, doi={10.1002/ijc.31275}, } @article{UBHD-68387877, author={Christopoulos, Petros and Kirchner, Martina and Bozorgmehr, Farastuk and Endris, Volker and El Sayed, Mei and Budczies, Jan and Ristau, Jonas and Penzel, Roland and Herth, Felix and Heußel, Claus Peter and Eichhorn, Martin E. and Muley, Thomas and Meister, Michael and Rieken, Stefan and Lasitschka, Felix and Bischoff, Helge and Sotillo, Rocio and Schirmacher, Peter and Thomas, Michael and Stenzinger, Albrecht}, title={Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma}, year={2019}, pages={190-199}, language={eng}, issn={1097-0215}, volume={144}, number={1}, note={Die Pluszeichen sind im Titel hochgestellt ; First published: 26 September 2018 ; Gesehen am07.05.2019}, journal={International journal of cancer}, doi={10.1002/ijc.31893}, } @article{UBHD-68389695, author={Christopoulos, Petros and Schneider, Marc and Bozorgmehr, Farastuk and Kuon, Jonas and Muley, Thomas and Bischoff, Helge and Thomas, Michael and Meister, Michael}, title={Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance}, year={2018}, pages={48-55}, language={eng}, issn={1872-8332}, volume={119}, note={Available online 6 March 2018 ; Gesehen am 14.05.2019}, journal={Lung cancer}, doi={10.1016/j.lungcan.2018.03.002}, } @article{UBHD-68681303, author={Christopoulos, Petros and Kirchner, Martina and Bozorgmehr, Farastuk and Magios, Nikolaus and Kazdal, Daniel and Volckmar, Anna-Lena and Br{\"u}ckner, Lena Marie and Bochtler, Tilmann and Kriegsmann, Mark and Endris, Volker and Penzel, Roland and Kriegsmann, Katharina and Eichhorn, Martin E. and Herth, Felix and Heußel, Claus Peter and El-Shafie, Rami and Schneider, Marc and Muley, Thomas and Meister, Michael and Schirmacher, Peter and Bischoff, Helge and Griesinger, Frank and Stenzinger, Albrecht and Thomas, Michael}, title={Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing}, year={2020}, pages={105-112}, language={eng}, issn={1872-8332}, volume={148}, note={Gesehen am 19.01.2021 ; Im Titel ist das Pluszeichen hochgestellt}, journal={Lung cancer}, doi={10.1016/j.lungcan.2020.08.007}, } @article{UBHD-69042597, author={Douillard, Jean-Yves and Shepherd, Frances A. and Hirsh, Vera and Mok, Tony and Socinski, Mark A. and Gervais, Radj and Liao, Mei-Lin and Bischoff, Helge and Reck, Martin and Sellers, Mark V. and Watkins, Claire L. and Speake, Georgina and Armour, Alison A. and Kim, Edward S.}, title={Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer}, subtitle={data from the randomized phase III INTEREST trial}, year={2010}, pages={744-752}, language={eng}, issn={1527-7755}, volume={28}, number={5}, note={Published online ahead of print at www.jco.org on December 28, 2009 ; Gesehen am 16.02.2023}, journal={Journal of clinical oncology}, doi={10.1200/JCO.2009.24.3030}, } @article{UBHD-68498109, author={Eichhorn, Florian and Klotz, Laura Valentina and Bischoff, Helge and Thomas, Michael and Lasitschka, Felix and Winter, Hauke and Hoffmann, Hans and Eichhorn, Martin E.}, title={Neoadjuvant anti-programmed death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC)}, subtitle={the NEOMUN trial}, year={2019}, pages={10 S.}, language={eng}, issn={1471-2407}, volume={19(2019) Artikel-Nummer 413}, number={8 Seiten}, note={Gesehen am 10.03.2020}, journal={BMC cancer}, doi={10.1186/s12885-019-5624-2}, } @book{UBHD-68419777, author={Eichhorn, Florian and Klotz, Laura Valentina and Bischoff, Helge and Thomas, Michael and Lasitschka, Felix and Winter, Hauke and Hoffmann, Hans and Eichhorn, Martin E.}, title={Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC)}, subtitle={the NEOMUN trial}, publisher={BioMed Central}, address={London}, year={2019}, pages={1 Online-Ressource}, language={eng}, note={In: BMC Cancer, 19 (2019), Nr. 413. pp. 1-8. ISSN 1471-2407}, url={https://nbn-resolving.org/urn:nbn:de:bsz:16-heidok-263980}, library={UB}, } @article{UBHD-68721811, author={Eichhorn, Florian and Klotz, Laura Valentina and Kriegsmann, Mark and Bischoff, Helge and Schneider, Marc and Muley, Thomas and Kriegsmann, Katharina and Haberkorn, Uwe and Heußel, Claus Peter and Savai, Rajkumar and Z{\"o}rnig, Inka and J{\"a}ger, Dirk and Thomas, Michael and Hoffmann, Hans and Winter, Hauke and Eichhorn, Martin E.}, title={Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer}, subtitle={first clinical experience}, year={2021}, pages={150-157}, language={eng}, issn={1872-8332}, volume={153}, note={Gesehen am 26.08.2021}, journal={Lung cancer}, doi={10.1016/j.lungcan.2021.01.018}, } @article{UBHD-68767361, author={Fisch, David and Bozorgmehr, Farastuk and Kazdal, Daniel and Kuon, Jonas and Klotz, Laura Valentina and Shah, Rajiv and Eichhorn, Florian and Kriegsmann, Mark and Schneider, Marc and Muley, Thomas and Stenzinger, Albrecht and Bischoff, Helge and Christopoulos, Petros}, title={Comprehensive dissection of treatment patterns and outcome for patients with metastatic large-cell neuroendocrine lung carcinoma}, year={2021}, pages={1-12}, language={eng}, issn={2234-943X}, volume={11(2021) vom: 8. Juli}, number={Artikel-ID 673901}, note={Gesehen am 05.08.2021}, journal={Frontiers in oncology}, doi={10.3389/fonc.2021.673901}, url={https://doi.org/10.3389/fonc.2021.673901}, library={UB}, } @article{UBHD-68734570, author={Gadgeel, Shirish and Rodríguez-Abreu, Delvys and Speranza, Giovanna and Esteban, Emilio and Felip, Enriqueta and Dómine, Manuel and Hui, Rina and Hochmair, Maximilian J. and Clingan, Philip and Powell, Steven F. and Cheng, Susanna Yee-Shan and Bischoff, Helge and Peled, Nir and Grossi, Francesco and Jennens, Ross R. and Reck, Martin and Garon, Edward B. and Novello, Silvia and Rubio-Viqueira, Belén and Boyer, Michael and Kurata, Takayasu and Gray, Jhanelle E. and Yang, Jing and Bas, Tuba and Pietanza, M. Catherine and Garassino, Marina C.}, title={Updated analysis from KEYNOTE-189}, subtitle={pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer}, year={2020}, pages={1505-1517}, language={eng}, issn={1527-7755}, volume={38}, number={14 vom: Mai}, note={Gesehen am 06.05.2021}, journal={Journal of clinical oncology}, doi={10.1200/JCO.19.03136}, } @article{UBHD-68467574, author={Gandhi, Leena and Bischoff, Helge}, title={Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer}, year={2018}, pages={2078-2092}, language={eng}, issn={1533-4406}, volume={378}, number={22}, note={Gesehen am 13.12.2019}, journal={The New England journal of medicine}, doi={10.1056/NEJMoa1801005}, } @article{UBHD-69044496, author={Garassino, Marina and Mazieres, Julien and Reck, Martin and Chouaid, Christos and Bischoff, Helge and Reinmuth, Niels and Cove-Smith, Laura and Mansy, Talal and Cortinovis, Diego and Migliorino, Maria R. and Delmonte, Angelo and Sánchez, José Garcia and Chara Velarde, Luis Enrique and Bernabe, Reyes and Paz-Ares, Luis and Perez, Ignacio Diaz and Trunova, Nataliya and Foroutanpour, Kayhan and Faivre-Finn, Corinne}, title={Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC}, subtitle={the phase 2 PACIFIC-6 trial}, year={2022}, pages={1415-1427}, language={eng}, issn={1556-1380}, volume={17}, number={12 vom: Dez.}, note={Gesehen am 14.11.2023}, journal={Journal of thoracic oncology}, doi={10.1016/j.jtho.2022.07.1148}, } @article{UBHD-68655652, author={Garassino, Marina and Gadgeel, Shirish and Esteban, Emilio and Felip, Enriqueta and Speranza, Giovanna and Domine, Manuel and Hochmair, Maximilian J. and Powell, Steven and Cheng, Susanna Yee-Shan and Bischoff, Helge and Peled, Nir and Reck, Martin and Hui, Rina and Garon, Edward B. and Boyer, Michael and Wei, Ziwen and Burke, Thomas and Pietanza, M. Catherine and Rodríguez-Abreu, Delvys}, title={Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189)}, subtitle={a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial}, year={2020}, pages={387-397}, language={eng}, issn={1474-5488}, volume={21}, number={3}, note={Gesehen am 30.10.2020}, journal={The lancet}, doi={10.1016/S1470-2045(19)30801-0}, } @article{UBHD-69128713, author={Garassino, Marina and Gadgeel, Shirish and Speranza, Giovanna and Felip, Enriqueta and Esteban, Emilio and Dómine, Manuel and Hochmair, Maximilian and Powell, Steven F. and Bischoff, Helge and Peled, Nir and Grossi, Francesco and Jennens, Ross R. and Reck, Martin and Hui, Rina and Garon, Edward B. and Kurata, Takayasu and Gray, Jhanelle E. and Schwarzenberger, Paul and Jensen, Erin and Pietanza, M. Catherine and Rodríguez-Abreu, Delvys}, title={Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer}, subtitle={5-year outcomes from the phase 3 KEYNOTE-189 study}, year={2023}, pages={1992-1998}, language={eng}, issn={1527-7755}, volume={41}, number={11 vom: Apr.}, note={7 gez{\"a}hlte Seiten (S. 1992-1998) sowie im Anschluss weitere 7 ungez{\"a}hlte Seiten ; Online ver{\"o}ffentlicht: 21. Februar 2023 ; Gesehen am 11.10.2023}, journal={Journal of clinical oncology}, doi={10.1200/JCO.22.01989}, } @article{UBHD-68725096, author={Goldman, Jonathan W. and Mazieres, Julien and Barlesi, Fabrice and Dragnev, Konstantin H. and Koczywas, Marianna and G{\"o}skel, Tuncay and Cortot, Alexis B. and Girard, Nicolas and Wesseler, Claas and Bischoff, Helge and Nadal, Ernest and Park, Keunchil and Lu, Shun and Taus, Alvaro and Cobo, Manuel and Estrem, Shawn T. and Wijayawardana, Sameera R. and Turner, Kellie and Oakley, Gerard Joseph III and Hurt, Karla C. and Chiang, Alan Y. and Hossain, Anwar M. and John, William J. and Paz-Ares, Luis}, title={A randomized phase III study of abemaciclib versus erlotinib in patients with stage IV non-small cell lung cancer with a detectable KRAS mutation who failed prior platinum-based therapy}, subtitle={JUNIPER}, year={2020}, pages={1-12}, language={eng}, issn={2234-943X}, volume={10}, number={Artikel-ID 578756}, note={Gesehen am 19.04.2021}, journal={Frontiers in oncology}, doi={10.3389/fonc.2020.578756}, } @article{UBHD-68243556, author={Gottschling, Sandra and Herpel, Esther and Eberhardt, Wilfried E. E. and K{\"o}hne, Claus-Henning and Kuhnt, Thomas and Muley, Thomas and Meister, Michael and Bischoff, Helge and Schnabel, Philipp Albert and Thomas, Michael and Penzel, Roland}, title={The gefitinib long-term responder (LTR) - a cancer stem-like cell story?}, subtitle={Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)}, year={2012}, pages={183-191}, language={eng}, issn={1872-8332}, volume={77}, number={1}, note={Gesehen am 17.04.2018}, journal={Lung cancer}, doi={10.1016/j.lungcan.2012.03.003}, } @article{UBHD-68737183, author={Herbst, Roy S. and Arkenau, Hendrik Tobias and Bendell, Johanna and Arrowsmith, Edward and Wermke, Martin and Soriano, Andres and Penel, Nicolas and Santana-Davila, Rafael and Bischoff, Helge and Chau, Ian and Mi, Gu and Wang, Hong and Rasmussen, Erik and Ferry, David and Chao, Bo H. and Paz-Ares, Luis}, title={Phase 1 expansion cohort of ramucirumab plus pembrolizumab in advanced treatment-naive NSCLC}, year={2021}, pages={289-298}, language={eng}, issn={1556-1380}, volume={16}, number={2}, note={Available online 15 October 2020 ; Gesehen am 12.05.2021}, journal={Journal of thoracic oncology}, doi={10.1016/j.jtho.2020.10.004}, } @article{UBHD-68469264, author={Kazdal, Daniel and Endris, Volker and Allg{\"a}uer, Michael and Kriegsmann, Mark and Leichsenring, Jonas and Volckmar, Anna-Lena and Harms, Alexander and Kirchner, Martina and Kriegsmann, Katharina and Neumann, Olaf and Brandt, Regine and Talla, Suranand Babu and Rempel, Eugen and Pl{\"o}ger, Carolin and Winterfeld, Moritz von and Christopoulos, Petros and Bischoff, Helge and Meister, Michael and Muley, Thomas and Herth, Felix and Penzel, Roland and Warth, Arne and Winter, Hauke and Fr{\"o}hling, Stefan and Thomas, Michael and Schirmacher, Peter and Budczies, Jan and Stenzinger, Albrecht}, title={Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma}, subtitle={separating biology from technical artifacts}, year={2019}, pages={1935-1947}, language={eng}, issn={1556-1380}, volume={14}, number={11}, note={Gesehen am 18.12.2019}, journal={Journal of thoracic oncology}, doi={10.1016/j.jtho.2019.07.006}, } @article{UBHD-68747491, author={Magios, Nikolaus and Bozorgmehr, Farastuk and Volckmar, Anna-Lena and Kazdal, Daniel and Kirchner, Martina and Herth, Felix and Heußel, Claus Peter and Eichhorn, Florian and Meister, Michael and Muley, Thomas and El-Shafie, Rami and Fischer, J{\"u}rgen and Faehling, Martin and Kriegsmann, Mark and Schirmacher, Peter and Bischoff, Helge and Stenzinger, Albrecht and Thomas, Michael and Christopoulos, Petros}, title={Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer}, year={2021}, pages={1-13}, language={eng}, issn={1758-8359}, volume={13(2021) vom: Jan.}, number={Artikel-ID 1758835921996509}, note={Gesehen am 12.06.2021}, journal={Therapeutic advances in medical oncology}, doi={10.1177/1758835921996509}, } @article{UBHD-69231097, author={Michels, Sebastian and Massutí, B. and Vasyliv, I. and Stratmann, J. and Frank, J. and Adams, A. and Felip, E. and Grohé, C. and Rodriguez-Abreu, D. and Bischoff, Helge and Carcereny i Costa, E. and Corral, J. and Pereira, E. and Fassunke, J. and Fischer, R. N. and Insa, A. and Koleczko, S. and Nogova, L. and Reck, M. and Reutter, T. and Riedel, R. and Schaufler, D. and Scheffler, M. and Weisthoff, M. and Provencio, M. and Merkelbach-Bruse, S. and Hellmich, M. and Sebastian, M. and B{\"u}ttner, R. and Persigehl, T. and Rosell, R. and Wolf, J.}, title={Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer}, subtitle={final results of the EUCROSS trial}, year={2024}, pages={1-10}, language={eng}, issn={2059-7029}, volume={9}, note={Gesehen am 05.07.2024 ; Online verf{\"u}gbar 12 February 2024, Version des Artikels 12 February 2024}, journal={ESMO open}, doi={10.1016/j.esmoop.2024.102237}, } @article{UBHD-68414946, author={Michels, Sebastian and Bischoff, Helge}, title={Safety and efficacy of crizotinib in patients with advanced or metastatic ROS1-rearranged lung cancer (EUCROSS)}, subtitle={a European phase II clinical trial}, year={2019}, pages={1266-1276}, language={eng}, issn={1556-1380}, volume={14}, number={7}, note={Gesehen am 01.08.2019}, journal={Journal of thoracic oncology}, doi={10.1016/j.jtho.2019.03.020}, } @article{UBHD-68871535, author={Mountzios, Giannis and Samantas, E. and Senghas, Karsten and Zervas, E. and Krisam, Johannes and Samitas, K. and Bozorgmehr, Farastuk and Kuon, Jonas and Agelaki, S. and Baka, S. and Athanasiadis, I. and Gaißmaier, Lena and Elshiaty, Mariam and Daniello, Lea and Christopoulou, A. and Pentheroudakis, G. and Lianos, E. and Linardou, H. and Kriegsmann, Katharina and Kosmidis, P. and El-Shafie, Rami and Kriegsmann, Mark and Psyrri, A. and Andreadis, C. and Fountzilas, E. and Heußel, Claus Peter and Herth, Felix and Winter, Hauke and Emmanouilides, C. and Oikonomopoulos, G. and Meister, Michael and Muley, Thomas and Bischoff, Helge and Saridaki, Z. and Razis, E. and Perdikouri, E. -I. and Stenzinger, Albrecht and Boukovinas, I. and Reck, M. and Syrigos, K. and Thomas, Michael and Christopoulos, Petros}, title={Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer}, year={2021}, pages={1-10}, language={eng}, issn={2059-7029}, volume={6}, note={Gesehen am 27.01.2022}, journal={ESMO open}, doi={10.1016/j.esmoop.2021.100254}, } @article{UBHD-68629378, author={Muley, Thomas and Sianidou, Maria and Bischoff, Helge and Schneider, Marc and Warth, Arne}, title={Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer}, year={2014}, pages={3707-3713}, language={eng}, issn={1791-7530}, volume={34}, number={7}, note={Gesehen am 20.08.2020}, journal={Anticancer research}, } @article{UBHD-69091838, author={Nuijten, Marcus Johannes Catharina and Heigener, David and Bischoff, Helge and Chouaid, Christos and Vergnenègre, Alain and de Castro Carpeño, Javier and Aultman, Rick and Walzer, Stefan and Siebert, Uwe}, title={Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer”}, year={2010}, pages={230}, language={eng}, issn={1872-8332}, volume={70}, number={2 vom: Nov.}, note={Gesehen am 30.06.2023}, journal={Lung cancer}, doi={10.1016/j.lungcan.2010.09.007}, } @article{UBHD-69091828, author={Nuijten, Marcus Johannes Catharina and Heigener, David F. and Bischoff, Helge and Chouaid, Christos and Vergnenègre, Alain and de Castro Carpeño, Javier and Aultman, Rick and Walzer, Stefan and Siebert, Uwe}, title={Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer}, year={2010}, pages={S4-S10}, language={eng}, issn={1872-8332}, volume={69}, number={Suppl. 1$m8}, note={Gesehen am 30.06.2023}, journal={Lung cancer}, doi={10.1016/S0169-5002(10)70132-X}, } @article{UBHD-68420978, author={Papachristofilou, Alexandros and Hipp, Madeleine M. and Klinkhardt, Ute and Fr{\"u}h, Martin and Sebastian, Martin and Weiss, Christian and Pless, Miklos and Cathomas, Richard Liberat and Hilbe, Wolfgang and Pall, Georg and Wehler, Thomas and Alt, J{\"u}rgen and Bischoff, Helge and Geißler, Michael and Griesinger, Frank and Kallen, Karl-Josef and Fotin-Mleczek, Mariola and Schr{\"o}der, Andreas and Scheel, Birgit and Muth, Anke and Seibel, Tobias and Stosnach, Claudia and Doener, Fatma and Hong, Henoch Sangjoon and Koch, Sven D. and Gnad-Vogt, Ulrike and Zippelius, Alfred}, title={Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849(CV9202), combined with local radiation treatment in patients with stage IVnon-small cell lung cancer}, year={2019}, pages={14 S.}, language={eng}, issn={2051-1426}, volume={vol. 7}, journal={Journal for ImmunoTherapy of Cancer}, doi={10.1186/s40425-019-0520-5}, } @book{UBHD-68388660, author={Papachristofilou, Alexandros and Sebastian, Martin and Bischoff, Helge}, title={Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer}, publisher={BioMed Central}, address={London}, year={2019}, pages={1 Online-Ressource}, language={eng}, note={In: Journal for ImmunoTherapy of Cancer, 7 (2019), Nr. 38. pp. 1-14. ISSN 2051-1426}, doi={10.1186/s40425-019-0520-5}, url={https://nbn-resolving.org/urn:nbn:de:bsz:16-heidok-260704}, library={UB}, } @article{UBHD-69032609, author={Reck, Martin and Mok, Tony S. K. and Mansfield, Aaron and De Boer, Richard and Losonczy, Gyorgy and Sugawara, Shunichi and Dziadziuszko, Rafal and Krzakowski, Maciej and Smolin, Alexey and Hochmair, Maximilian and Garassino, Marina Chiara and de Castro Junior, Gilberto and Bischoff, Helge and Lam, Sivuonthanh and Cardona, Andres and Morris, Stefanie and Liu, Stephen V.}, title={Brief report: Exploratory analysis of maintenance therapy in patients with extensive-stage SCLC treated first line with Atezolizumab plus carboplatin and etoposide}, year={2022}, pages={1122-1129}, language={eng}, issn={1556-1380}, volume={17}, number={9}, note={Online verf{\"u}gbar 25 Juni 2022, Artikelversion 26 August 2022 ; Gesehen am 01.02.2023}, journal={Journal of thoracic oncology}, doi={10.1016/j.jtho.2022.05.016}, } @article{UBHD-68251067, author={Reinmuth, Niels and Stumpf, Andreas and Stumpf, Patrick and Muley, Thomas and Kobinger, Sonja and Hoffmann, Hans and Herth, Felix and Schnabel, Philipp Albert and Warth, Arne and Bischoff, Helge and Thomas, Michael}, title={Characteristics and outcome of patients with second primary lung cancer}, year={2013}, pages={1668-1676}, language={eng}, issn={1399-3003}, volume={42}, number={6}, note={First published online: Oct 11 2012 ; Gesehen am 09.05.2018}, journal={The European respiratory journal}, doi={10.1183/09031936.00022512}, } @article{UBHD-68627568, author={Reinmuth, Niels and Stumpf, Patrick and Stumpf, Andreas and Muley, Thomas and Kobinger, Sonja and Hoffmann, Hans and Herth, Felix and Schnabel, Philipp Albert and Bischoff, Helge and Thomas, Michael}, title={Characteristics of lung cancer after a previous malignancy}, year={2014}, pages={910-917}, language={eng}, issn={1532-3064}, volume={108}, number={6}, note={Gesehen am 14.08.2020}, journal={Respiratory medicine}, doi={10.1016/j.rmed.2014.02.015}, } @article{UBHD-68618056, author={Rheinheimer, Stephan and Heußel, Claus Peter and Mayer, Philipp and Bozorgmehr, Farastuk and Winter, Hauke and Herth, Felix and Muley, Thomas and Liersch, Stephan and Bischoff, Helge and Kriegsmann, Mark and El-Shafie, Rami and Stenzinger, Albrecht and Thomas, Michael and Kauczor, Hans-Ulrich and Christopoulos, Petros}, title={Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors}, year={2020}, pages={1-13}, language={eng}, issn={2072-6694}, volume={12}, note={Gesehen am 17.07.2020}, journal={Cancers}, doi={10.3390/cancers12041046}, } @article{UBHD-68761587, author={Rodríguez-Abreu, Delvys and Bischoff, Helge}, title={Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC}, subtitle={protocol-specified final analysis from KEYNOTE-189}, year={2021}, pages={881-895}, language={eng}, issn={1569-8041}, volume={32}, number={7}, note={Available online 22 April 2021 ; Gesehen am 20.07.2021}, journal={Annals of oncology}, doi={10.1016/j.annonc.2021.04.008}, } @article{UBHD-69143967, author={Steins, Martin and Reinmuth, Niels and Bischoff, Helge and Kindermann, Markus and Thomas, Michael}, title={Targeting the epidermal growth factor receptor in non-small cell lung cancer}, year={2010}, pages={704-709}, language={eng}, issn={1423-0240}, volume={33}, number={12}, note={Gesehen am 17.11.2023}, journal={Onkologie}, doi={10.1159/000322214}, } @article{UBHD-68497618, author={Stratmann, Jan A. and Michels, Sebastian and Hornetz, Sofia Emily Tsion and Christoph, Daniel C. and Sackmann, Sandra and Spengle, Werner and Bischoff, Helge and Biscaldi-Sch{\"a}fer, Verona Monica and Alt, J{\"u}rgen and M{\"u}ller, Annette and Laack, Eckart and Kimmich, Martin and Griesinger, Frank and Sebastian, Martin}, title={Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer}, year={2018}, pages={2457-2463}, language={eng}, issn={1432-1335}, volume={144}, number={12}, journal={Journal of cancer research and clinical oncology}, doi={10.1007/s00432-018-2754-x}, } @article{UBHD-68680721, author={Wessels, Sabine and Muley, Thomas and Christopoulos, Petros and Meister, Michael and Heinzmann-Groth, Ingrid and Warth, Arne and Herpel, Esther and Hummler, Simone and Klingm{\"u}ller, Ursula and Kuon, Jonas and Heußel, Claus Peter and Eberhardt, Ralf and Herth, Felix and Winter, Hauke and Bischoff, Helge and Stenzinger, Albrecht and Thomas, Michael and Schneider, Marc}, title={Comprehensive serial biobanking in advanced NSCLC}, subtitle={feasibility, challenges and perspectives}, year={2020}, pages={1000-1014}, language={eng}, issn={2226-4477}, volume={9}, number={4}, note={Gesehen am 26.10.2021}, journal={Translational Lung Cancer Research}, doi={10.21037/tlcr-20-137}, } @article{UBHD-68615325, author={Yamauchi, Yoshikane and Muley, Thomas and Safi, Seyer and Rieken, Stefan and Bischoff, Helge and Kappes, Jutta and Warth, Arne and Herth, Felix and Dienemann, Hendrik and Hoffmann, Hans}, title={The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients}, subtitle={experiences at a single institution}, year={2015}, pages={224-229}, language={eng}, issn={1872-8332}, volume={90}, number={2}, note={Gesehen am 09.07.2020}, journal={Lung cancer}, doi={10.1016/j.lungcan.2015.09.010}, }